Global Melatonin

Melatonin Comprehensive Study by Type (Pharmaceutical Grade, Food Grade), Application (Dietary Supplements, Medical, Others), Form (Pill, Capsule, Chewable, Liquid, Gummy), Distribution Channel (Offline, Online) Players and Region - Global Market Outlook to 2026

Melatonin Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Melatonin Market Scope?
Melatonin is a hormone that regulates the sleep-wake cycle. The melatonin market is expected to grow exponentially during the forecast period owing to the increasing used for the short-term treatment of trouble sleeping such as from jet lag or shift work and work as medication ramelteon. Also, Increasing the use of pharmaceutical supplements boosting the demand for melatonin such as used in the treatment of neurodegenerative.

The Melatonin market study is being classified by Type (Pharmaceutical Grade and Food Grade), by Application (Dietary Supplements, Medical and Others) and major geographies with country level break-up.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Melatonin market throughout the predicted period.

Natrol (United States), Pharmavite (United States), Nature's Bounty (United States), Jamieson Laboratories (Canada), Rexall Sundown (United States), GNC Holdings Inc (United States), By-Health Co., Ltd. (China), Pfizer Inc. (United States) and Solgar (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biotics Research (United States) and Now Food (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Melatonin market by Type, Application and Region.

On the basis of geography, the market of Melatonin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Use of Melatonin in the Treatment of Neurodegenerative and Neoplastic Diseases

Market Drivers
  • Increasing Adoption of Phramacitacal and Dietary Supplement Product
  • Rising Demand from Women with Endometriosis Disease

Opportunities
  • Rapid Industrialization in Emerging Countries
  • Growth in the Pharmaceutical Industry in Developing Countries

Restraints
  • Stringent Government Regulation on the Use of Melatonin
  • Fluctuation in the Price of Raw Material

Challenges
  • Side-effect such as Headache, Daytime Sleepiness, Dizziness


Key Target Audience
Melatonin Manufacturer, Supplier/Distributors, Raw Material Suppliers, Pharmaceuticals and Potential Investors

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceutical Grade
  • Food Grade
By Application
  • Dietary Supplements
  • Medical
  • Others
By Form
  • Pill
  • Capsule
  • Chewable
  • Liquid
  • Gummy

By Distribution Channel
  • Offline
  • Online

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Phramacitacal and Dietary Supplement Product
      • 3.2.2. Rising Demand from Women with Endometriosis Disease
    • 3.3. Market Challenges
      • 3.3.1. Side-effect such as Headache, Daytime Sleepiness, Dizziness
    • 3.4. Market Trends
      • 3.4.1. Use of Melatonin in the Treatment of Neurodegenerative and Neoplastic Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Melatonin, by Type, Application, Form, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Melatonin (Value)
      • 5.2.1. Global Melatonin by: Type (Value)
        • 5.2.1.1. Pharmaceutical Grade
        • 5.2.1.2. Food Grade
      • 5.2.2. Global Melatonin by: Application (Value)
        • 5.2.2.1. Dietary Supplements
        • 5.2.2.2. Medical
        • 5.2.2.3. Others
      • 5.2.3. Global Melatonin by: Form (Value)
        • 5.2.3.1. Pill
        • 5.2.3.2. Capsule
        • 5.2.3.3. Chewable
        • 5.2.3.4. Liquid
        • 5.2.3.5. Gummy
      • 5.2.4. Global Melatonin by: Distribution Channel (Value)
        • 5.2.4.1. Offline
        • 5.2.4.2. Online
      • 5.2.5. Global Melatonin Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Melatonin (Volume)
      • 5.3.1. Global Melatonin by: Type (Volume)
        • 5.3.1.1. Pharmaceutical Grade
        • 5.3.1.2. Food Grade
      • 5.3.2. Global Melatonin by: Application (Volume)
        • 5.3.2.1. Dietary Supplements
        • 5.3.2.2. Medical
        • 5.3.2.3. Others
      • 5.3.3. Global Melatonin by: Form (Volume)
        • 5.3.3.1. Pill
        • 5.3.3.2. Capsule
        • 5.3.3.3. Chewable
        • 5.3.3.4. Liquid
        • 5.3.3.5. Gummy
      • 5.3.4. Global Melatonin by: Distribution Channel (Volume)
        • 5.3.4.1. Offline
        • 5.3.4.2. Online
      • 5.3.5. Global Melatonin Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Melatonin (Price)
      • 5.4.1. Global Melatonin by: Type (Price)
  • 6. Melatonin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Natrol (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pharmavite (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nature's Bounty (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jamieson Laboratories (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Rexall Sundown (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GNC Holdings Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. By-Health Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pfizer Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Solgar (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Melatonin Sale, by Type, Application, Form, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Melatonin (Value)
      • 7.2.1. Global Melatonin by: Type (Value)
        • 7.2.1.1. Pharmaceutical Grade
        • 7.2.1.2. Food Grade
      • 7.2.2. Global Melatonin by: Application (Value)
        • 7.2.2.1. Dietary Supplements
        • 7.2.2.2. Medical
        • 7.2.2.3. Others
      • 7.2.3. Global Melatonin by: Form (Value)
        • 7.2.3.1. Pill
        • 7.2.3.2. Capsule
        • 7.2.3.3. Chewable
        • 7.2.3.4. Liquid
        • 7.2.3.5. Gummy
      • 7.2.4. Global Melatonin by: Distribution Channel (Value)
        • 7.2.4.1. Offline
        • 7.2.4.2. Online
      • 7.2.5. Global Melatonin Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Melatonin (Volume)
      • 7.3.1. Global Melatonin by: Type (Volume)
        • 7.3.1.1. Pharmaceutical Grade
        • 7.3.1.2. Food Grade
      • 7.3.2. Global Melatonin by: Application (Volume)
        • 7.3.2.1. Dietary Supplements
        • 7.3.2.2. Medical
        • 7.3.2.3. Others
      • 7.3.3. Global Melatonin by: Form (Volume)
        • 7.3.3.1. Pill
        • 7.3.3.2. Capsule
        • 7.3.3.3. Chewable
        • 7.3.3.4. Liquid
        • 7.3.3.5. Gummy
      • 7.3.4. Global Melatonin by: Distribution Channel (Volume)
        • 7.3.4.1. Offline
        • 7.3.4.2. Online
      • 7.3.5. Global Melatonin Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Melatonin (Price)
      • 7.4.1. Global Melatonin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Melatonin: by Type(USD Million)
  • Table 2. Melatonin Pharmaceutical Grade , by Region USD Million (2015-2020)
  • Table 3. Melatonin Food Grade , by Region USD Million (2015-2020)
  • Table 4. Melatonin: by Application(USD Million)
  • Table 5. Melatonin Dietary Supplements , by Region USD Million (2015-2020)
  • Table 6. Melatonin Medical , by Region USD Million (2015-2020)
  • Table 7. Melatonin Others , by Region USD Million (2015-2020)
  • Table 8. Melatonin: by Form(USD Million)
  • Table 9. Melatonin Pill , by Region USD Million (2015-2020)
  • Table 10. Melatonin Capsule , by Region USD Million (2015-2020)
  • Table 11. Melatonin Chewable , by Region USD Million (2015-2020)
  • Table 12. Melatonin Liquid , by Region USD Million (2015-2020)
  • Table 13. Melatonin Gummy , by Region USD Million (2015-2020)
  • Table 14. Melatonin: by Distribution Channel(USD Million)
  • Table 15. Melatonin Offline , by Region USD Million (2015-2020)
  • Table 16. Melatonin Online , by Region USD Million (2015-2020)
  • Table 17. South America Melatonin, by Country USD Million (2015-2020)
  • Table 18. South America Melatonin, by Type USD Million (2015-2020)
  • Table 19. South America Melatonin, by Application USD Million (2015-2020)
  • Table 20. South America Melatonin, by Form USD Million (2015-2020)
  • Table 21. South America Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 22. Brazil Melatonin, by Type USD Million (2015-2020)
  • Table 23. Brazil Melatonin, by Application USD Million (2015-2020)
  • Table 24. Brazil Melatonin, by Form USD Million (2015-2020)
  • Table 25. Brazil Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 26. Argentina Melatonin, by Type USD Million (2015-2020)
  • Table 27. Argentina Melatonin, by Application USD Million (2015-2020)
  • Table 28. Argentina Melatonin, by Form USD Million (2015-2020)
  • Table 29. Argentina Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 30. Rest of South America Melatonin, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Melatonin, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Melatonin, by Form USD Million (2015-2020)
  • Table 33. Rest of South America Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 34. Asia Pacific Melatonin, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Melatonin, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Melatonin, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Melatonin, by Form USD Million (2015-2020)
  • Table 38. Asia Pacific Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 39. China Melatonin, by Type USD Million (2015-2020)
  • Table 40. China Melatonin, by Application USD Million (2015-2020)
  • Table 41. China Melatonin, by Form USD Million (2015-2020)
  • Table 42. China Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 43. Japan Melatonin, by Type USD Million (2015-2020)
  • Table 44. Japan Melatonin, by Application USD Million (2015-2020)
  • Table 45. Japan Melatonin, by Form USD Million (2015-2020)
  • Table 46. Japan Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 47. India Melatonin, by Type USD Million (2015-2020)
  • Table 48. India Melatonin, by Application USD Million (2015-2020)
  • Table 49. India Melatonin, by Form USD Million (2015-2020)
  • Table 50. India Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 51. South Korea Melatonin, by Type USD Million (2015-2020)
  • Table 52. South Korea Melatonin, by Application USD Million (2015-2020)
  • Table 53. South Korea Melatonin, by Form USD Million (2015-2020)
  • Table 54. South Korea Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 55. Taiwan Melatonin, by Type USD Million (2015-2020)
  • Table 56. Taiwan Melatonin, by Application USD Million (2015-2020)
  • Table 57. Taiwan Melatonin, by Form USD Million (2015-2020)
  • Table 58. Taiwan Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 59. Australia Melatonin, by Type USD Million (2015-2020)
  • Table 60. Australia Melatonin, by Application USD Million (2015-2020)
  • Table 61. Australia Melatonin, by Form USD Million (2015-2020)
  • Table 62. Australia Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Melatonin, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Melatonin, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Melatonin, by Form USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 67. Europe Melatonin, by Country USD Million (2015-2020)
  • Table 68. Europe Melatonin, by Type USD Million (2015-2020)
  • Table 69. Europe Melatonin, by Application USD Million (2015-2020)
  • Table 70. Europe Melatonin, by Form USD Million (2015-2020)
  • Table 71. Europe Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 72. Germany Melatonin, by Type USD Million (2015-2020)
  • Table 73. Germany Melatonin, by Application USD Million (2015-2020)
  • Table 74. Germany Melatonin, by Form USD Million (2015-2020)
  • Table 75. Germany Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 76. France Melatonin, by Type USD Million (2015-2020)
  • Table 77. France Melatonin, by Application USD Million (2015-2020)
  • Table 78. France Melatonin, by Form USD Million (2015-2020)
  • Table 79. France Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 80. Italy Melatonin, by Type USD Million (2015-2020)
  • Table 81. Italy Melatonin, by Application USD Million (2015-2020)
  • Table 82. Italy Melatonin, by Form USD Million (2015-2020)
  • Table 83. Italy Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 84. United Kingdom Melatonin, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Melatonin, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Melatonin, by Form USD Million (2015-2020)
  • Table 87. United Kingdom Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 88. Netherlands Melatonin, by Type USD Million (2015-2020)
  • Table 89. Netherlands Melatonin, by Application USD Million (2015-2020)
  • Table 90. Netherlands Melatonin, by Form USD Million (2015-2020)
  • Table 91. Netherlands Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 92. Rest of Europe Melatonin, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Melatonin, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Melatonin, by Form USD Million (2015-2020)
  • Table 95. Rest of Europe Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 96. MEA Melatonin, by Country USD Million (2015-2020)
  • Table 97. MEA Melatonin, by Type USD Million (2015-2020)
  • Table 98. MEA Melatonin, by Application USD Million (2015-2020)
  • Table 99. MEA Melatonin, by Form USD Million (2015-2020)
  • Table 100. MEA Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 101. Middle East Melatonin, by Type USD Million (2015-2020)
  • Table 102. Middle East Melatonin, by Application USD Million (2015-2020)
  • Table 103. Middle East Melatonin, by Form USD Million (2015-2020)
  • Table 104. Middle East Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 105. Africa Melatonin, by Type USD Million (2015-2020)
  • Table 106. Africa Melatonin, by Application USD Million (2015-2020)
  • Table 107. Africa Melatonin, by Form USD Million (2015-2020)
  • Table 108. Africa Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 109. North America Melatonin, by Country USD Million (2015-2020)
  • Table 110. North America Melatonin, by Type USD Million (2015-2020)
  • Table 111. North America Melatonin, by Application USD Million (2015-2020)
  • Table 112. North America Melatonin, by Form USD Million (2015-2020)
  • Table 113. North America Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 114. United States Melatonin, by Type USD Million (2015-2020)
  • Table 115. United States Melatonin, by Application USD Million (2015-2020)
  • Table 116. United States Melatonin, by Form USD Million (2015-2020)
  • Table 117. United States Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 118. Canada Melatonin, by Type USD Million (2015-2020)
  • Table 119. Canada Melatonin, by Application USD Million (2015-2020)
  • Table 120. Canada Melatonin, by Form USD Million (2015-2020)
  • Table 121. Canada Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 122. Mexico Melatonin, by Type USD Million (2015-2020)
  • Table 123. Mexico Melatonin, by Application USD Million (2015-2020)
  • Table 124. Mexico Melatonin, by Form USD Million (2015-2020)
  • Table 125. Mexico Melatonin, by Distribution Channel USD Million (2015-2020)
  • Table 126. Melatonin Sales: by Type(K Unit)
  • Table 127. Melatonin Sales Pharmaceutical Grade , by Region K Unit (2015-2020)
  • Table 128. Melatonin Sales Food Grade , by Region K Unit (2015-2020)
  • Table 129. Melatonin Sales: by Application(K Unit)
  • Table 130. Melatonin Sales Dietary Supplements , by Region K Unit (2015-2020)
  • Table 131. Melatonin Sales Medical , by Region K Unit (2015-2020)
  • Table 132. Melatonin Sales Others , by Region K Unit (2015-2020)
  • Table 133. Melatonin Sales: by Form(K Unit)
  • Table 134. Melatonin Sales Pill , by Region K Unit (2015-2020)
  • Table 135. Melatonin Sales Capsule , by Region K Unit (2015-2020)
  • Table 136. Melatonin Sales Chewable , by Region K Unit (2015-2020)
  • Table 137. Melatonin Sales Liquid , by Region K Unit (2015-2020)
  • Table 138. Melatonin Sales Gummy , by Region K Unit (2015-2020)
  • Table 139. Melatonin Sales: by Distribution Channel(K Unit)
  • Table 140. Melatonin Sales Offline , by Region K Unit (2015-2020)
  • Table 141. Melatonin Sales Online , by Region K Unit (2015-2020)
  • Table 142. South America Melatonin Sales, by Country K Unit (2015-2020)
  • Table 143. South America Melatonin Sales, by Type K Unit (2015-2020)
  • Table 144. South America Melatonin Sales, by Application K Unit (2015-2020)
  • Table 145. South America Melatonin Sales, by Form K Unit (2015-2020)
  • Table 146. South America Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 147. Brazil Melatonin Sales, by Type K Unit (2015-2020)
  • Table 148. Brazil Melatonin Sales, by Application K Unit (2015-2020)
  • Table 149. Brazil Melatonin Sales, by Form K Unit (2015-2020)
  • Table 150. Brazil Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 151. Argentina Melatonin Sales, by Type K Unit (2015-2020)
  • Table 152. Argentina Melatonin Sales, by Application K Unit (2015-2020)
  • Table 153. Argentina Melatonin Sales, by Form K Unit (2015-2020)
  • Table 154. Argentina Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 155. Rest of South America Melatonin Sales, by Type K Unit (2015-2020)
  • Table 156. Rest of South America Melatonin Sales, by Application K Unit (2015-2020)
  • Table 157. Rest of South America Melatonin Sales, by Form K Unit (2015-2020)
  • Table 158. Rest of South America Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 159. Asia Pacific Melatonin Sales, by Country K Unit (2015-2020)
  • Table 160. Asia Pacific Melatonin Sales, by Type K Unit (2015-2020)
  • Table 161. Asia Pacific Melatonin Sales, by Application K Unit (2015-2020)
  • Table 162. Asia Pacific Melatonin Sales, by Form K Unit (2015-2020)
  • Table 163. Asia Pacific Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 164. China Melatonin Sales, by Type K Unit (2015-2020)
  • Table 165. China Melatonin Sales, by Application K Unit (2015-2020)
  • Table 166. China Melatonin Sales, by Form K Unit (2015-2020)
  • Table 167. China Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 168. Japan Melatonin Sales, by Type K Unit (2015-2020)
  • Table 169. Japan Melatonin Sales, by Application K Unit (2015-2020)
  • Table 170. Japan Melatonin Sales, by Form K Unit (2015-2020)
  • Table 171. Japan Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 172. India Melatonin Sales, by Type K Unit (2015-2020)
  • Table 173. India Melatonin Sales, by Application K Unit (2015-2020)
  • Table 174. India Melatonin Sales, by Form K Unit (2015-2020)
  • Table 175. India Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 176. South Korea Melatonin Sales, by Type K Unit (2015-2020)
  • Table 177. South Korea Melatonin Sales, by Application K Unit (2015-2020)
  • Table 178. South Korea Melatonin Sales, by Form K Unit (2015-2020)
  • Table 179. South Korea Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 180. Taiwan Melatonin Sales, by Type K Unit (2015-2020)
  • Table 181. Taiwan Melatonin Sales, by Application K Unit (2015-2020)
  • Table 182. Taiwan Melatonin Sales, by Form K Unit (2015-2020)
  • Table 183. Taiwan Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 184. Australia Melatonin Sales, by Type K Unit (2015-2020)
  • Table 185. Australia Melatonin Sales, by Application K Unit (2015-2020)
  • Table 186. Australia Melatonin Sales, by Form K Unit (2015-2020)
  • Table 187. Australia Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 188. Rest of Asia-Pacific Melatonin Sales, by Type K Unit (2015-2020)
  • Table 189. Rest of Asia-Pacific Melatonin Sales, by Application K Unit (2015-2020)
  • Table 190. Rest of Asia-Pacific Melatonin Sales, by Form K Unit (2015-2020)
  • Table 191. Rest of Asia-Pacific Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 192. Europe Melatonin Sales, by Country K Unit (2015-2020)
  • Table 193. Europe Melatonin Sales, by Type K Unit (2015-2020)
  • Table 194. Europe Melatonin Sales, by Application K Unit (2015-2020)
  • Table 195. Europe Melatonin Sales, by Form K Unit (2015-2020)
  • Table 196. Europe Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 197. Germany Melatonin Sales, by Type K Unit (2015-2020)
  • Table 198. Germany Melatonin Sales, by Application K Unit (2015-2020)
  • Table 199. Germany Melatonin Sales, by Form K Unit (2015-2020)
  • Table 200. Germany Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 201. France Melatonin Sales, by Type K Unit (2015-2020)
  • Table 202. France Melatonin Sales, by Application K Unit (2015-2020)
  • Table 203. France Melatonin Sales, by Form K Unit (2015-2020)
  • Table 204. France Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 205. Italy Melatonin Sales, by Type K Unit (2015-2020)
  • Table 206. Italy Melatonin Sales, by Application K Unit (2015-2020)
  • Table 207. Italy Melatonin Sales, by Form K Unit (2015-2020)
  • Table 208. Italy Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 209. United Kingdom Melatonin Sales, by Type K Unit (2015-2020)
  • Table 210. United Kingdom Melatonin Sales, by Application K Unit (2015-2020)
  • Table 211. United Kingdom Melatonin Sales, by Form K Unit (2015-2020)
  • Table 212. United Kingdom Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 213. Netherlands Melatonin Sales, by Type K Unit (2015-2020)
  • Table 214. Netherlands Melatonin Sales, by Application K Unit (2015-2020)
  • Table 215. Netherlands Melatonin Sales, by Form K Unit (2015-2020)
  • Table 216. Netherlands Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 217. Rest of Europe Melatonin Sales, by Type K Unit (2015-2020)
  • Table 218. Rest of Europe Melatonin Sales, by Application K Unit (2015-2020)
  • Table 219. Rest of Europe Melatonin Sales, by Form K Unit (2015-2020)
  • Table 220. Rest of Europe Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 221. MEA Melatonin Sales, by Country K Unit (2015-2020)
  • Table 222. MEA Melatonin Sales, by Type K Unit (2015-2020)
  • Table 223. MEA Melatonin Sales, by Application K Unit (2015-2020)
  • Table 224. MEA Melatonin Sales, by Form K Unit (2015-2020)
  • Table 225. MEA Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 226. Middle East Melatonin Sales, by Type K Unit (2015-2020)
  • Table 227. Middle East Melatonin Sales, by Application K Unit (2015-2020)
  • Table 228. Middle East Melatonin Sales, by Form K Unit (2015-2020)
  • Table 229. Middle East Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 230. Africa Melatonin Sales, by Type K Unit (2015-2020)
  • Table 231. Africa Melatonin Sales, by Application K Unit (2015-2020)
  • Table 232. Africa Melatonin Sales, by Form K Unit (2015-2020)
  • Table 233. Africa Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 234. North America Melatonin Sales, by Country K Unit (2015-2020)
  • Table 235. North America Melatonin Sales, by Type K Unit (2015-2020)
  • Table 236. North America Melatonin Sales, by Application K Unit (2015-2020)
  • Table 237. North America Melatonin Sales, by Form K Unit (2015-2020)
  • Table 238. North America Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 239. United States Melatonin Sales, by Type K Unit (2015-2020)
  • Table 240. United States Melatonin Sales, by Application K Unit (2015-2020)
  • Table 241. United States Melatonin Sales, by Form K Unit (2015-2020)
  • Table 242. United States Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 243. Canada Melatonin Sales, by Type K Unit (2015-2020)
  • Table 244. Canada Melatonin Sales, by Application K Unit (2015-2020)
  • Table 245. Canada Melatonin Sales, by Form K Unit (2015-2020)
  • Table 246. Canada Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 247. Mexico Melatonin Sales, by Type K Unit (2015-2020)
  • Table 248. Mexico Melatonin Sales, by Application K Unit (2015-2020)
  • Table 249. Mexico Melatonin Sales, by Form K Unit (2015-2020)
  • Table 250. Mexico Melatonin Sales, by Distribution Channel K Unit (2015-2020)
  • Table 251. Melatonin: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Melatonin: by Type(USD Million)
  • Table 262. Melatonin Pharmaceutical Grade , by Region USD Million (2021-2026)
  • Table 263. Melatonin Food Grade , by Region USD Million (2021-2026)
  • Table 264. Melatonin: by Application(USD Million)
  • Table 265. Melatonin Dietary Supplements , by Region USD Million (2021-2026)
  • Table 266. Melatonin Medical , by Region USD Million (2021-2026)
  • Table 267. Melatonin Others , by Region USD Million (2021-2026)
  • Table 268. Melatonin: by Form(USD Million)
  • Table 269. Melatonin Pill , by Region USD Million (2021-2026)
  • Table 270. Melatonin Capsule , by Region USD Million (2021-2026)
  • Table 271. Melatonin Chewable , by Region USD Million (2021-2026)
  • Table 272. Melatonin Liquid , by Region USD Million (2021-2026)
  • Table 273. Melatonin Gummy , by Region USD Million (2021-2026)
  • Table 274. Melatonin: by Distribution Channel(USD Million)
  • Table 275. Melatonin Offline , by Region USD Million (2021-2026)
  • Table 276. Melatonin Online , by Region USD Million (2021-2026)
  • Table 277. South America Melatonin, by Country USD Million (2021-2026)
  • Table 278. South America Melatonin, by Type USD Million (2021-2026)
  • Table 279. South America Melatonin, by Application USD Million (2021-2026)
  • Table 280. South America Melatonin, by Form USD Million (2021-2026)
  • Table 281. South America Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 282. Brazil Melatonin, by Type USD Million (2021-2026)
  • Table 283. Brazil Melatonin, by Application USD Million (2021-2026)
  • Table 284. Brazil Melatonin, by Form USD Million (2021-2026)
  • Table 285. Brazil Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 286. Argentina Melatonin, by Type USD Million (2021-2026)
  • Table 287. Argentina Melatonin, by Application USD Million (2021-2026)
  • Table 288. Argentina Melatonin, by Form USD Million (2021-2026)
  • Table 289. Argentina Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 290. Rest of South America Melatonin, by Type USD Million (2021-2026)
  • Table 291. Rest of South America Melatonin, by Application USD Million (2021-2026)
  • Table 292. Rest of South America Melatonin, by Form USD Million (2021-2026)
  • Table 293. Rest of South America Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 294. Asia Pacific Melatonin, by Country USD Million (2021-2026)
  • Table 295. Asia Pacific Melatonin, by Type USD Million (2021-2026)
  • Table 296. Asia Pacific Melatonin, by Application USD Million (2021-2026)
  • Table 297. Asia Pacific Melatonin, by Form USD Million (2021-2026)
  • Table 298. Asia Pacific Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 299. China Melatonin, by Type USD Million (2021-2026)
  • Table 300. China Melatonin, by Application USD Million (2021-2026)
  • Table 301. China Melatonin, by Form USD Million (2021-2026)
  • Table 302. China Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 303. Japan Melatonin, by Type USD Million (2021-2026)
  • Table 304. Japan Melatonin, by Application USD Million (2021-2026)
  • Table 305. Japan Melatonin, by Form USD Million (2021-2026)
  • Table 306. Japan Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 307. India Melatonin, by Type USD Million (2021-2026)
  • Table 308. India Melatonin, by Application USD Million (2021-2026)
  • Table 309. India Melatonin, by Form USD Million (2021-2026)
  • Table 310. India Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 311. South Korea Melatonin, by Type USD Million (2021-2026)
  • Table 312. South Korea Melatonin, by Application USD Million (2021-2026)
  • Table 313. South Korea Melatonin, by Form USD Million (2021-2026)
  • Table 314. South Korea Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 315. Taiwan Melatonin, by Type USD Million (2021-2026)
  • Table 316. Taiwan Melatonin, by Application USD Million (2021-2026)
  • Table 317. Taiwan Melatonin, by Form USD Million (2021-2026)
  • Table 318. Taiwan Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 319. Australia Melatonin, by Type USD Million (2021-2026)
  • Table 320. Australia Melatonin, by Application USD Million (2021-2026)
  • Table 321. Australia Melatonin, by Form USD Million (2021-2026)
  • Table 322. Australia Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 323. Rest of Asia-Pacific Melatonin, by Type USD Million (2021-2026)
  • Table 324. Rest of Asia-Pacific Melatonin, by Application USD Million (2021-2026)
  • Table 325. Rest of Asia-Pacific Melatonin, by Form USD Million (2021-2026)
  • Table 326. Rest of Asia-Pacific Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 327. Europe Melatonin, by Country USD Million (2021-2026)
  • Table 328. Europe Melatonin, by Type USD Million (2021-2026)
  • Table 329. Europe Melatonin, by Application USD Million (2021-2026)
  • Table 330. Europe Melatonin, by Form USD Million (2021-2026)
  • Table 331. Europe Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 332. Germany Melatonin, by Type USD Million (2021-2026)
  • Table 333. Germany Melatonin, by Application USD Million (2021-2026)
  • Table 334. Germany Melatonin, by Form USD Million (2021-2026)
  • Table 335. Germany Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 336. France Melatonin, by Type USD Million (2021-2026)
  • Table 337. France Melatonin, by Application USD Million (2021-2026)
  • Table 338. France Melatonin, by Form USD Million (2021-2026)
  • Table 339. France Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 340. Italy Melatonin, by Type USD Million (2021-2026)
  • Table 341. Italy Melatonin, by Application USD Million (2021-2026)
  • Table 342. Italy Melatonin, by Form USD Million (2021-2026)
  • Table 343. Italy Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 344. United Kingdom Melatonin, by Type USD Million (2021-2026)
  • Table 345. United Kingdom Melatonin, by Application USD Million (2021-2026)
  • Table 346. United Kingdom Melatonin, by Form USD Million (2021-2026)
  • Table 347. United Kingdom Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 348. Netherlands Melatonin, by Type USD Million (2021-2026)
  • Table 349. Netherlands Melatonin, by Application USD Million (2021-2026)
  • Table 350. Netherlands Melatonin, by Form USD Million (2021-2026)
  • Table 351. Netherlands Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 352. Rest of Europe Melatonin, by Type USD Million (2021-2026)
  • Table 353. Rest of Europe Melatonin, by Application USD Million (2021-2026)
  • Table 354. Rest of Europe Melatonin, by Form USD Million (2021-2026)
  • Table 355. Rest of Europe Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 356. MEA Melatonin, by Country USD Million (2021-2026)
  • Table 357. MEA Melatonin, by Type USD Million (2021-2026)
  • Table 358. MEA Melatonin, by Application USD Million (2021-2026)
  • Table 359. MEA Melatonin, by Form USD Million (2021-2026)
  • Table 360. MEA Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 361. Middle East Melatonin, by Type USD Million (2021-2026)
  • Table 362. Middle East Melatonin, by Application USD Million (2021-2026)
  • Table 363. Middle East Melatonin, by Form USD Million (2021-2026)
  • Table 364. Middle East Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 365. Africa Melatonin, by Type USD Million (2021-2026)
  • Table 366. Africa Melatonin, by Application USD Million (2021-2026)
  • Table 367. Africa Melatonin, by Form USD Million (2021-2026)
  • Table 368. Africa Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 369. North America Melatonin, by Country USD Million (2021-2026)
  • Table 370. North America Melatonin, by Type USD Million (2021-2026)
  • Table 371. North America Melatonin, by Application USD Million (2021-2026)
  • Table 372. North America Melatonin, by Form USD Million (2021-2026)
  • Table 373. North America Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 374. United States Melatonin, by Type USD Million (2021-2026)
  • Table 375. United States Melatonin, by Application USD Million (2021-2026)
  • Table 376. United States Melatonin, by Form USD Million (2021-2026)
  • Table 377. United States Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 378. Canada Melatonin, by Type USD Million (2021-2026)
  • Table 379. Canada Melatonin, by Application USD Million (2021-2026)
  • Table 380. Canada Melatonin, by Form USD Million (2021-2026)
  • Table 381. Canada Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 382. Mexico Melatonin, by Type USD Million (2021-2026)
  • Table 383. Mexico Melatonin, by Application USD Million (2021-2026)
  • Table 384. Mexico Melatonin, by Form USD Million (2021-2026)
  • Table 385. Mexico Melatonin, by Distribution Channel USD Million (2021-2026)
  • Table 386. Melatonin Sales: by Type(K Unit)
  • Table 387. Melatonin Sales Pharmaceutical Grade , by Region K Unit (2021-2026)
  • Table 388. Melatonin Sales Food Grade , by Region K Unit (2021-2026)
  • Table 389. Melatonin Sales: by Application(K Unit)
  • Table 390. Melatonin Sales Dietary Supplements , by Region K Unit (2021-2026)
  • Table 391. Melatonin Sales Medical , by Region K Unit (2021-2026)
  • Table 392. Melatonin Sales Others , by Region K Unit (2021-2026)
  • Table 393. Melatonin Sales: by Form(K Unit)
  • Table 394. Melatonin Sales Pill , by Region K Unit (2021-2026)
  • Table 395. Melatonin Sales Capsule , by Region K Unit (2021-2026)
  • Table 396. Melatonin Sales Chewable , by Region K Unit (2021-2026)
  • Table 397. Melatonin Sales Liquid , by Region K Unit (2021-2026)
  • Table 398. Melatonin Sales Gummy , by Region K Unit (2021-2026)
  • Table 399. Melatonin Sales: by Distribution Channel(K Unit)
  • Table 400. Melatonin Sales Offline , by Region K Unit (2021-2026)
  • Table 401. Melatonin Sales Online , by Region K Unit (2021-2026)
  • Table 402. South America Melatonin Sales, by Country K Unit (2021-2026)
  • Table 403. South America Melatonin Sales, by Type K Unit (2021-2026)
  • Table 404. South America Melatonin Sales, by Application K Unit (2021-2026)
  • Table 405. South America Melatonin Sales, by Form K Unit (2021-2026)
  • Table 406. South America Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 407. Brazil Melatonin Sales, by Type K Unit (2021-2026)
  • Table 408. Brazil Melatonin Sales, by Application K Unit (2021-2026)
  • Table 409. Brazil Melatonin Sales, by Form K Unit (2021-2026)
  • Table 410. Brazil Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 411. Argentina Melatonin Sales, by Type K Unit (2021-2026)
  • Table 412. Argentina Melatonin Sales, by Application K Unit (2021-2026)
  • Table 413. Argentina Melatonin Sales, by Form K Unit (2021-2026)
  • Table 414. Argentina Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 415. Rest of South America Melatonin Sales, by Type K Unit (2021-2026)
  • Table 416. Rest of South America Melatonin Sales, by Application K Unit (2021-2026)
  • Table 417. Rest of South America Melatonin Sales, by Form K Unit (2021-2026)
  • Table 418. Rest of South America Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 419. Asia Pacific Melatonin Sales, by Country K Unit (2021-2026)
  • Table 420. Asia Pacific Melatonin Sales, by Type K Unit (2021-2026)
  • Table 421. Asia Pacific Melatonin Sales, by Application K Unit (2021-2026)
  • Table 422. Asia Pacific Melatonin Sales, by Form K Unit (2021-2026)
  • Table 423. Asia Pacific Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 424. China Melatonin Sales, by Type K Unit (2021-2026)
  • Table 425. China Melatonin Sales, by Application K Unit (2021-2026)
  • Table 426. China Melatonin Sales, by Form K Unit (2021-2026)
  • Table 427. China Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 428. Japan Melatonin Sales, by Type K Unit (2021-2026)
  • Table 429. Japan Melatonin Sales, by Application K Unit (2021-2026)
  • Table 430. Japan Melatonin Sales, by Form K Unit (2021-2026)
  • Table 431. Japan Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 432. India Melatonin Sales, by Type K Unit (2021-2026)
  • Table 433. India Melatonin Sales, by Application K Unit (2021-2026)
  • Table 434. India Melatonin Sales, by Form K Unit (2021-2026)
  • Table 435. India Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 436. South Korea Melatonin Sales, by Type K Unit (2021-2026)
  • Table 437. South Korea Melatonin Sales, by Application K Unit (2021-2026)
  • Table 438. South Korea Melatonin Sales, by Form K Unit (2021-2026)
  • Table 439. South Korea Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 440. Taiwan Melatonin Sales, by Type K Unit (2021-2026)
  • Table 441. Taiwan Melatonin Sales, by Application K Unit (2021-2026)
  • Table 442. Taiwan Melatonin Sales, by Form K Unit (2021-2026)
  • Table 443. Taiwan Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 444. Australia Melatonin Sales, by Type K Unit (2021-2026)
  • Table 445. Australia Melatonin Sales, by Application K Unit (2021-2026)
  • Table 446. Australia Melatonin Sales, by Form K Unit (2021-2026)
  • Table 447. Australia Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 448. Rest of Asia-Pacific Melatonin Sales, by Type K Unit (2021-2026)
  • Table 449. Rest of Asia-Pacific Melatonin Sales, by Application K Unit (2021-2026)
  • Table 450. Rest of Asia-Pacific Melatonin Sales, by Form K Unit (2021-2026)
  • Table 451. Rest of Asia-Pacific Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 452. Europe Melatonin Sales, by Country K Unit (2021-2026)
  • Table 453. Europe Melatonin Sales, by Type K Unit (2021-2026)
  • Table 454. Europe Melatonin Sales, by Application K Unit (2021-2026)
  • Table 455. Europe Melatonin Sales, by Form K Unit (2021-2026)
  • Table 456. Europe Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 457. Germany Melatonin Sales, by Type K Unit (2021-2026)
  • Table 458. Germany Melatonin Sales, by Application K Unit (2021-2026)
  • Table 459. Germany Melatonin Sales, by Form K Unit (2021-2026)
  • Table 460. Germany Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 461. France Melatonin Sales, by Type K Unit (2021-2026)
  • Table 462. France Melatonin Sales, by Application K Unit (2021-2026)
  • Table 463. France Melatonin Sales, by Form K Unit (2021-2026)
  • Table 464. France Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 465. Italy Melatonin Sales, by Type K Unit (2021-2026)
  • Table 466. Italy Melatonin Sales, by Application K Unit (2021-2026)
  • Table 467. Italy Melatonin Sales, by Form K Unit (2021-2026)
  • Table 468. Italy Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 469. United Kingdom Melatonin Sales, by Type K Unit (2021-2026)
  • Table 470. United Kingdom Melatonin Sales, by Application K Unit (2021-2026)
  • Table 471. United Kingdom Melatonin Sales, by Form K Unit (2021-2026)
  • Table 472. United Kingdom Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 473. Netherlands Melatonin Sales, by Type K Unit (2021-2026)
  • Table 474. Netherlands Melatonin Sales, by Application K Unit (2021-2026)
  • Table 475. Netherlands Melatonin Sales, by Form K Unit (2021-2026)
  • Table 476. Netherlands Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 477. Rest of Europe Melatonin Sales, by Type K Unit (2021-2026)
  • Table 478. Rest of Europe Melatonin Sales, by Application K Unit (2021-2026)
  • Table 479. Rest of Europe Melatonin Sales, by Form K Unit (2021-2026)
  • Table 480. Rest of Europe Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 481. MEA Melatonin Sales, by Country K Unit (2021-2026)
  • Table 482. MEA Melatonin Sales, by Type K Unit (2021-2026)
  • Table 483. MEA Melatonin Sales, by Application K Unit (2021-2026)
  • Table 484. MEA Melatonin Sales, by Form K Unit (2021-2026)
  • Table 485. MEA Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 486. Middle East Melatonin Sales, by Type K Unit (2021-2026)
  • Table 487. Middle East Melatonin Sales, by Application K Unit (2021-2026)
  • Table 488. Middle East Melatonin Sales, by Form K Unit (2021-2026)
  • Table 489. Middle East Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 490. Africa Melatonin Sales, by Type K Unit (2021-2026)
  • Table 491. Africa Melatonin Sales, by Application K Unit (2021-2026)
  • Table 492. Africa Melatonin Sales, by Form K Unit (2021-2026)
  • Table 493. Africa Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 494. North America Melatonin Sales, by Country K Unit (2021-2026)
  • Table 495. North America Melatonin Sales, by Type K Unit (2021-2026)
  • Table 496. North America Melatonin Sales, by Application K Unit (2021-2026)
  • Table 497. North America Melatonin Sales, by Form K Unit (2021-2026)
  • Table 498. North America Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 499. United States Melatonin Sales, by Type K Unit (2021-2026)
  • Table 500. United States Melatonin Sales, by Application K Unit (2021-2026)
  • Table 501. United States Melatonin Sales, by Form K Unit (2021-2026)
  • Table 502. United States Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 503. Canada Melatonin Sales, by Type K Unit (2021-2026)
  • Table 504. Canada Melatonin Sales, by Application K Unit (2021-2026)
  • Table 505. Canada Melatonin Sales, by Form K Unit (2021-2026)
  • Table 506. Canada Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 507. Mexico Melatonin Sales, by Type K Unit (2021-2026)
  • Table 508. Mexico Melatonin Sales, by Application K Unit (2021-2026)
  • Table 509. Mexico Melatonin Sales, by Form K Unit (2021-2026)
  • Table 510. Mexico Melatonin Sales, by Distribution Channel K Unit (2021-2026)
  • Table 511. Melatonin: by Type(USD/Units)
  • Table 512. Research Programs/Design for This Report
  • Table 513. Key Data Information from Secondary Sources
  • Table 514. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Melatonin: by Type USD Million (2015-2020)
  • Figure 5. Global Melatonin: by Application USD Million (2015-2020)
  • Figure 6. Global Melatonin: by Form USD Million (2015-2020)
  • Figure 7. Global Melatonin: by Distribution Channel USD Million (2015-2020)
  • Figure 8. South America Melatonin Share (%), by Country
  • Figure 9. Asia Pacific Melatonin Share (%), by Country
  • Figure 10. Europe Melatonin Share (%), by Country
  • Figure 11. MEA Melatonin Share (%), by Country
  • Figure 12. North America Melatonin Share (%), by Country
  • Figure 13. Global Melatonin: by Type K Unit (2015-2020)
  • Figure 14. Global Melatonin: by Application K Unit (2015-2020)
  • Figure 15. Global Melatonin: by Form K Unit (2015-2020)
  • Figure 16. Global Melatonin: by Distribution Channel K Unit (2015-2020)
  • Figure 17. South America Melatonin Share (%), by Country
  • Figure 18. Asia Pacific Melatonin Share (%), by Country
  • Figure 19. Europe Melatonin Share (%), by Country
  • Figure 20. MEA Melatonin Share (%), by Country
  • Figure 21. North America Melatonin Share (%), by Country
  • Figure 22. Global Melatonin: by Type USD/Units (2015-2020)
  • Figure 23. Global Melatonin share by Players 2020 (%)
  • Figure 24. Global Melatonin share by Players (Top 3) 2020(%)
  • Figure 25. Global Melatonin share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Natrol (United States) Revenue, Net Income and Gross profit
  • Figure 28. Natrol (United States) Revenue: by Geography 2020
  • Figure 29. Pharmavite (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pharmavite (United States) Revenue: by Geography 2020
  • Figure 31. Nature's Bounty (United States) Revenue, Net Income and Gross profit
  • Figure 32. Nature's Bounty (United States) Revenue: by Geography 2020
  • Figure 33. Jamieson Laboratories (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Jamieson Laboratories (Canada) Revenue: by Geography 2020
  • Figure 35. Rexall Sundown (United States) Revenue, Net Income and Gross profit
  • Figure 36. Rexall Sundown (United States) Revenue: by Geography 2020
  • Figure 37. GNC Holdings Inc (United States) Revenue, Net Income and Gross profit
  • Figure 38. GNC Holdings Inc (United States) Revenue: by Geography 2020
  • Figure 39. By-Health Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 40. By-Health Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 41. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Solgar (United States) Revenue, Net Income and Gross profit
  • Figure 44. Solgar (United States) Revenue: by Geography 2020
  • Figure 45. Global Melatonin: by Type USD Million (2021-2026)
  • Figure 46. Global Melatonin: by Application USD Million (2021-2026)
  • Figure 47. Global Melatonin: by Form USD Million (2021-2026)
  • Figure 48. Global Melatonin: by Distribution Channel USD Million (2021-2026)
  • Figure 49. South America Melatonin Share (%), by Country
  • Figure 50. Asia Pacific Melatonin Share (%), by Country
  • Figure 51. Europe Melatonin Share (%), by Country
  • Figure 52. MEA Melatonin Share (%), by Country
  • Figure 53. North America Melatonin Share (%), by Country
  • Figure 54. Global Melatonin: by Type K Unit (2021-2026)
  • Figure 55. Global Melatonin: by Application K Unit (2021-2026)
  • Figure 56. Global Melatonin: by Form K Unit (2021-2026)
  • Figure 57. Global Melatonin: by Distribution Channel K Unit (2021-2026)
  • Figure 58. South America Melatonin Share (%), by Country
  • Figure 59. Asia Pacific Melatonin Share (%), by Country
  • Figure 60. Europe Melatonin Share (%), by Country
  • Figure 61. MEA Melatonin Share (%), by Country
  • Figure 62. North America Melatonin Share (%), by Country
  • Figure 63. Global Melatonin: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Natrol (United States)
  • Pharmavite (United States)
  • Nature's Bounty (United States)
  • Jamieson Laboratories (Canada)
  • Rexall Sundown (United States)
  • GNC Holdings Inc (United States)
  • By-Health Co., Ltd. (China)
  • Pfizer Inc. (United States)
  • Solgar (United States)
Additional players considered in the study are as follows:
Biotics Research (United States) , Now Food (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 220 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Melatonin Quantitative research analysis
Global Melatonin Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Melatonin market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Melatonin market are Natrol (United States), Pharmavite (United States), Nature's Bounty (United States), Jamieson Laboratories (Canada), Rexall Sundown (United States), GNC Holdings Inc (United States), By-Health Co., Ltd. (China), Pfizer Inc. (United States) and Solgar (United States), to name a few.
In this highly competitive & fast evolving Melatonin industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Melatonin Report?

Have a Query? Click Here

Other Related Reports

Opioids Drug Comprehensive Study by Type (Morphine, Codeine, Fentanyl, Meperidine, Methadone, Others), Application (Pain Management, Cough Supression, Diarrhea Suppresion, Others), Receptor Binding (...
$ 3350
Plaque Disclosing Comprehensive Study by Type (Plaque Disclosing Tablets, Plaque Disclosing Solution, Plaque Disclosing Swabs), Application (Children, Adults, The Old), Indication (Sub-gingival denta...
$ 3350
Orally Disintegrating Tablet Comprehensive Study by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy), Manufacturing Technique (Conventional techniques, Patented...
$ 3750
Porcine Epidemic Diarrhea Vaccines Comprehensive Study by Type (Live, Killed), Application (Adult Pigs, Piglets), End Users (Veterinary Hospitals, Hog Production Farm) Players and Region - Global Mar...
$ 3500
Medical Cannabis Comprehensive Study by Active Ingredients (Tetrahydrocannabinol {THC}, Cannabidiol {CBD}), Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), Therapeutic Application (...
$ 3650
Dementia Drugs Comprehensive Study by Type (MAO Inhibitors, Cholinesterase Inhibitors, Glutamate Inhibitors), Application (Hospital, Clinics, Others), Indication (Lewy Body Dementia, Parkinsons Disea...
$ 3650